keyword
https://read.qxmd.com/read/38464767/catatonia-a-deep-dive-into-its-unfathomable-depths
#1
EDITORIAL
Peter Phiri, Gayathri Delanerolle, Oliver Hope, Tharangini Murugaiyan, Geoffrey Dimba, Shanaya Rathod, Zukiswa Zingela
This editorial addresses catatonia, a complex neuropsychiatric syndrome characterised by a spectrum of psychomotor disturbances. The editorial seeks to clarify the ambiguous aspects of catatonia, integrating recent research findings, including global studies and diagnostic advancements. It discusses catatonia's clinical manifestations, prevalence, and associated psychiatric and medical conditions, with particular emphasis on its frequent co-occurrence with schizophrenia and mood disorders. The prevalence of catatonia, which varies across psychiatric populations, is illustrated by a significant study conducted in Nelson Mandela Bay, South Africa...
February 19, 2024: World Journal of Psychiatry
https://read.qxmd.com/read/38313968/neuropsychiatric-disorders-bridging-the-gap-between-neurology-and-psychiatry
#2
REVIEW
Sanzida Taslim, Sujeet Shadmani, Abdul Rehman Saleem, Ajay Kumar, Fnu Brahma, Narendar Blank, Muhammad Arsalan Bashir, Danya Ansari, Komal Kumari, Muhammad Tanveer, Giustino Varrassi, Satesh Kumar, Arveen Raj
Given the ongoing difficulties faced by clinicians and researchers in dealing with neuropsychiatric illnesses, it is becoming more and more evident that there is a need to go beyond traditional disciplinary boundaries. This research consolidates existing material, examining changes in history, the fundamental neurobiological aspects, and the shared clinical manifestations between neurology and psychiatry. This inquiry examines the historical development of neuropsychiatry, focusing on the relationship between early understandings of mental illness and the later division of neurology and psychiatry...
January 2024: Curēus
https://read.qxmd.com/read/38149145/exploring-neuropsychiatry-contemporary-challenges-breakthroughs-and-philosophical-perspectives
#3
EDITORIAL
José Carlos Medina-Rodríguez
This editorial provides a concise and updated overview of neuropsychiatry, emphasizing its definitional challenges and profound implications for education, training, research, and the integration of phenomenology and philosophy of mind. Neuropsychiatry, situated at the crossroads of neurology and psychiatry, grapples with complex definitional issues that impede research progress. Establishing a unified conceptual framework is essential for focused research and delving into fundamental questions regarding topics like "consciousness...
November 2023: Curēus
https://read.qxmd.com/read/37849313/association-between-psychosocial-stress-and-brain-aging-results-of-the-population-based-cohort-study-of-health-in-pomerania-ship
#4
JOURNAL ARTICLE
Francisca S Rodriguez, Hans J Grabe, Stefan Frenzel, Johanna Klinger-König, Robin Bülow, Henry Völzke, Wolfgang Hoffmann
OBJECTIVE: Recent studies suggest that psychosocial factors can have an impact on brain health. Yet, it is unclear whether psychosocial stress affects aging of the brain. The aim of the study was to investigate the association between psychosocial stress and brain aging. METHODS: Data from the German population-based cohort Study of Health in Pomerania (N=991; age range 20-78 years) were used to calculate a total psychosocial stress score by combining subscores from five domains: stress related to the living situation, the occupational situation, the social situation, danger experiences, and emotions...
October 18, 2023: Journal of Neuropsychiatry and Clinical Neurosciences
https://read.qxmd.com/read/36949318/a-link-between-inflammatory-mechanisms-and-fibromyalgia
#5
MULTICENTER STUDY
Ashika Bains, Samuel Kohrman, Diana Punko, Gregory Fricchione
Fibromyalgia (FM) is a condition characterized by chronic widespread pain, which has traditionally been considered psychogenic in nature due to lack of known underlying organic pathophysiology. In more recent years, inflammation of the nervous system has become increasingly recognized as a sign of neuropsychiatric conditions, and this association may enhance our knowledge of conditions such as FM. Emerging evidence has suggested inflammation, particularly neuroinflammation, as a potential contributor underlying the etiology of FM...
2023: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/36860320/monoamine-oxidase-a-an-emerging-therapeutic-target-in-prostate-cancer
#6
REVIEW
Chia-Hui Chen, Boyang Jason Wu
Monoamine oxidase A (MAOA), a mitochondrial enzyme degrading biogenic and dietary amines, has been studied in the contexts of neuropsychiatry and neurological disorders for decades, but its importance in oncology, as best exemplified in prostate cancer (PC) to date, was only realized recently. PC is the most commonly diagnosed non-skin cancer and the second deadliest malignancy for men in the United States. In PC, the increased expression level of MAOA is correlated with dedifferentiated tissue microarchitecture and a worse prognosis...
2023: Frontiers in Oncology
https://read.qxmd.com/read/36831972/salivary-diagnostics-in-pediatrics-and-the-status-of-saliva-based-biosensors
#7
REVIEW
Hayeon Min, Sophie Zhu, Lydia Safi, Munzer Alkourdi, Bich Hong Nguyen, Akshaya Upadhyay, Simon D Tran
Salivary biomarkers are increasingly being used as an alternative to diagnose and monitor the progression of various diseases due to their ease of use, on site application, non-invasiveness, and most likely improved patient compliance. Here, we highlight the role of salivary biosensors in the general population, followed by the application of saliva as a diagnostic tool in the pediatric population. We searched the literature for pediatric applications of salivary biomarkers, more specifically, in children from 0 to 18 years old...
January 30, 2023: Biosensors
https://read.qxmd.com/read/35893238/mir-218-a-stress-responsive-epigenetic-modifier
#8
REVIEW
Grant Schell, Bhaskar Roy, Kevin Prall, Yogesh Dwivedi
Understanding the epigenetic role of microRNAs (miRNAs) has been a critical development in the field of neuropsychiatry and in understanding their underlying pathophysiology. Abnormalities in miRNA expression are often seen as key to the pathogenesis of many stress-associated mental disorders, including major depressive disorder (MDD). Recent advances in omics biology have further contributed to this understanding and expanded the role of miRNAs in networking a diverse array of molecular pathways, which are essentially related to the stress adaptivity of a healthy brain...
July 21, 2022: Non-Coding RNA
https://read.qxmd.com/read/35821872/is-alexithymia-the-link-between-anorexia-and-autism-spectrum-disorders
#9
JOURNAL ARTICLE
Mario Miniati, Donatella Marazziti, Laura Palagini
Objective: Alexithymia main features include deficits in empathy, emotion recognition and regulation. Alexithymia has been recently proposed as a potential key to explain the presence of the so-called 'autistic spectrum disorder' signs (ASD), in patients with Anorexia Nervosa (AN). Objective of this review is to summarize current knowledge on the potential role of alexithymia in linking ASD and AN. Method: A systematic search has been conducted on PUBMED database of the last 10 years, in accordance with PRISMA Guidelines, applying queries in the 'PubMed Advanced Search Builder'...
June 2022: Clinical Neuropsychiatry
https://read.qxmd.com/read/35441333/updates-in-functional-movement-disorders-from-pathophysiology-to-treatment-advances
#10
REVIEW
Sushma Kola, Kathrin LaFaver
PURPOSE OF REVIEW: This review discusses advances in functional movement disorders (FMD) over the past 3 years, with a focus on risk factors, diagnosis, pathophysiology, neuroimaging studies, and treatment. RECENT FINDINGS: The past decade has brought a revived interest in functional movement disorders, with a growing number of studies exploring pathophysiological mechanisms. Here, we review recent studies demonstrating changes in attention, emotional and sensorimotor function in FMD...
May 2022: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/35306961/towards-a-neural-network-hypothesis-for-functional-cognitive-disorders-an-extension-of-the-overfitted-brain-hypothesis
#11
JOURNAL ARTICLE
A J Larner
Introduction: Whilst the empirical understanding of functional cognitive disorders (FCD) has advanced in recent years, theoretical and conceptual models have evolved more slowly. Existing frameworks for FCD are based on models of other functional neurological disorders or of metacognitive processes and are recognised to lack mechanistic precision. Methods: In this article, a novel application to FCD of Hoel's Overfitted Brain Hypothesis of the evolved function of dreaming is attempted. Results: This posits that the empirically observed sleep disturbance in FCD entails impaired dreaming which causes the brain to be overfitted and hence unable to generalise appropriately, producing mismatch between memory expectations and memory performance...
March 21, 2022: Cognitive Neuropsychiatry
https://read.qxmd.com/read/35073206/remote-patient-monitoring-for-neuropsychiatric-disorders-a-scoping-review-of-current-trends-and-future-perspectives-from-recent-publications-and-upcoming-clinical-trials
#12
REVIEW
Tetsuo Sakamaki, Yoshihiko Furusawa, Ayako Hayashi, Masaru Otsuka, Jovelle Fernandez
Introduction: Telemedicine and remote patient monitoring are rapidly growing fields. This scoping review provides an update on remote patient monitoring for neuropsychiatric disorders from recent publications and upcoming clinical trials. Methods: Publications (PubMed and ICHUSHI; published January 2010 to February 2021) and trials (ClinicalTrials.gov and Japanese registries; active or recruiting by March 2021) that assessed wearable devices for remote management and/or monitoring of patients with neuropsychiatric disorders were searched...
September 2022: Telemedicine Journal and E-health
https://read.qxmd.com/read/35055161/new-insights-and-potential-therapeutic-targeting-of-cb2-cannabinoid-receptors-in-cns-disorders
#13
REVIEW
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, Emmanuel S Onaivi
The endocannabinoid system (ECS) is ubiquitous in most human tissues, and involved in the regulation of mental health. Consequently, its dysregulation is associated with neuropsychiatric and neurodegenerative disorders. Together, the ECS and the expanded endocannabinoidome (eCBome) are composed of genes coding for CB1 and CB2 cannabinoid receptors (CB1R, CB2R), endocannabinoids (eCBs), and the metabolic enzyme machinery for their synthesis and catabolism. The activation of CB1R is associated with adverse effects on the central nervous system (CNS), which has limited the therapeutic use of drugs that bind this receptor...
January 17, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/34824146/functional-psychogenic-non-epileptic-dissociative-seizures-why-and-how
#14
REVIEW
Deniz Ertan, Selma Aybek, W Curt LaFrance, Kousuke Kanemoto, Alexis Tarrada, Louis Maillard, Wissam El-Hage, Coraline Hingray
Functional seizures (FS) known also as psychogenic non-epileptic seizures or dissociative seizures, present with ictal semiological manifestations, along with various comorbid neurological and psychological disorders. Terminology inconsistencies and discrepancies in nomenclatures of FS may reflect limitations in understanding the neuropsychiatric intricacies of this disorder. Psychological and neurobiological processes of FS are incompletely understood. Nevertheless, important advances have been made on underlying neuropsychopathophysiological mechanisms of FS...
February 2022: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/34340526/cognitive-dysfunction-in-white-matter-disorders-new-perspectives-in-treatment-and-recovery
#15
JOURNAL ARTICLE
Christopher M Filley
White matter disorders are increasingly appreciated as capable of disrupting cognitive function, and this impairment may be sufficiently severe to produce the syndrome of white matter dementia. Although recognizing this problem is important for diagnostic accuracy, the treatment of cognitive dysfunction and dementia in the white matter disorders has received relatively little attention. Similarly, few data are available regarding the potential for cognitive recovery in these disorders. Recent clinical and laboratory advances, however, indicate that effective treatment and meaningful recovery may be achievable goals for many patients with macrostructural or microstructural white matter pathology...
2021: Journal of Neuropsychiatry and Clinical Neurosciences
https://read.qxmd.com/read/34063505/the-therapeutic-potential-of-psilocybin
#16
REVIEW
Henry Lowe, Ngeh Toyang, Blair Steele, Henkel Valentine, Justin Grant, Amza Ali, Wilfred Ngwa, Lorenzo Gordon
The psychedelic effects of some plants and fungi have been known and deliberately exploited by humans for thousands of years. Fungi, particularly mushrooms, are the principal source of naturally occurring psychedelics. The mushroom extract, psilocybin has historically been used as a psychedelic agent for religious and spiritual ceremonies, as well as a therapeutic option for neuropsychiatric conditions. Psychedelic use was largely associated with the "hippie" counterculture movement, which, in turn, resulted in a growing, and still lingering, negative stigmatization for psychedelics...
May 15, 2021: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/33985346/developing-precision-invasive-neuromodulation-for-psychiatry
#17
JOURNAL ARTICLE
Nicholas L Bormann, Nicholas T Trapp, Nandakumar S Narayanan, Aaron D Boes
Psychiatric conditions are common and often disabling. Although great strides have been made in alleviating symptoms with pharmacotherapy and psychotherapeutic approaches, many patients continue to have severe disease burden despite the best therapies available. One of the pervasive challenges to improving treatment is that present diagnostic and therapeutic strategies lag behind our modern conceptualization of the pathophysiology of these disorders. Psychiatric symptoms manifest through activity in specific neural circuits; thus, therapies capable of modulating these circuits are attractive...
2021: Journal of Neuropsychiatry and Clinical Neurosciences
https://read.qxmd.com/read/33922390/neurofilaments-as-emerging-biomarkers-of-neuroaxonal-damage-to-differentiate-behavioral-frontotemporal-dementia-from-primary-psychiatric-disorders-a-systematic-review
#18
REVIEW
Vincent Davy, Julien Dumurgier, Aurore Fayosse, Claire Paquet, Emmanuel Cognat
The behavioral variant of frontotemporal dementia (bvFTD) is a clinical syndrome resulting from various causes of neuronal demises associated with frontotemporal lobar degeneration. Symptoms include behavioral and personality changes, social cognitive impairment, and executive function deficits. There is a significant clinical overlap between this syndrome and various primary psychiatric disorders (PPD). Structural and functional neuroimaging are considered helpful to support the diagnosis of bvFTD, but their sensitivity and specificity remain imperfect...
April 22, 2021: Diagnostics
https://read.qxmd.com/read/33722822/decade-of-progress-in-motor-functional-neurological-disorder-continuing-the-momentum
#19
REVIEW
David L Perez, Mark J Edwards, Glenn Nielsen, Kasia Kozlowska, Mark Hallett, W Curt LaFrance
Functional neurological disorder (FND) is a prevalent, disabling and costly condition at the neurology-psychiatry intersection. After being marginalised in the late 20th century, there has been renewed interest in this field. In this article, we review advances that have occurred over the past decade (2011-2020) across diagnosis, mechanisms, aetiologies, treatments and stigma in patients with motor FND (mFND, that is, functional movement disorder and functional limb weakness). In each content area, we also discuss the implications of recent advances and suggest future directions that will help continue the momentum of the past decade...
March 15, 2021: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/33441154/new-approaches-to-symptomatic-treatments-for-alzheimer-s-disease
#20
REVIEW
Jeffrey Cummings
BACKGROUND: Successful development of agents that improve cognition and behavior in Alzheimer's disease (AD) is critical to improving the lives of patients manifesting the symptoms of this progressive disorder. DISCUSSION: There have been no recent approvals of cognitive enhancing agents for AD. There are currently 6 cognitive enhancers in Phase 2 trials and 4 in phase 3. They represent a variety of novel mechanisms. There has been progress in developing new treatments for neuropsychiatric symptoms in AD with advances in treatment of insomnia, psychosis, apathy, and agitation in AD...
January 13, 2021: Molecular Neurodegeneration
keyword
keyword
93224
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.